Pourbaghi M, Haghani L, Zhao K, Karimi A, Marinelli B, Erinjeri J
Curr Oncol. 2023; 30(7):6609-6622.
PMID: 37504345
PMC: 10377758.
DOI: 10.3390/curroncol30070485.
Mackie P, Thomson M, Levine D, Branch R
Br J Clin Pharmacol. 2012; 3(4):613-9.
PMID: 22216503
PMC: 1428893.
DOI: 10.1111/j.1365-2125.1976.tb04884.x.
Lee S, Lee M, Kim N
J Pharmacokinet Biopharm. 1994; 22(1):1-17.
PMID: 8027946
DOI: 10.1007/BF02353407.
Pentikainen P, Neuvonen P, Kekki M, Penttila A
J Pharmacokinet Biopharm. 1980; 8(3):219-28.
PMID: 7420267
DOI: 10.1007/BF01059643.
Marcantonio L, AULD W, Skellern G, Howes C, MURDOCH W, Purohit R
J Pharmacokinet Biopharm. 1982; 10(4):393-409.
PMID: 7153872
DOI: 10.1007/BF01065171.
Treatment of nephrotic edema with bumetanide.
LEMIEUX G, Beauchemin M, Gougoux A, Vinay P
Can Med Assoc J. 1981; 125(10):1111-2, 1117.
PMID: 7034916
PMC: 1862648.
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
Verho M, Rangoonwala B, DOLS W, Fratzer U, Kaczynski J, Muhlhausler W
Eur J Clin Pharmacol. 1984; 27(4):407-14.
PMID: 6394349
DOI: 10.1007/BF00549586.
Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
Ward A, Heel R
Drugs. 1984; 28(5):426-64.
PMID: 6391889
DOI: 10.2165/00003495-198428050-00003.
Use of bumetanide in the treatment of ascites due to liver disease.
Moult P, Lunzer M, Trash D, Sherlock S
Gut. 1974; 15(12):988-92.
PMID: 4448415
PMC: 1413073.
DOI: 10.1136/gut.15.12.988.
Effect of bumetanide in capillary permeability pulmonary oedema.
Ali J, Duke K
Can J Anaesth. 1987; 34(1):9-13.
PMID: 3829293
DOI: 10.1007/BF03007674.
Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.
Lambe R, Kennedy O, Kenny M, Darragh A
Eur J Clin Pharmacol. 1986; 31 Suppl:9-14.
PMID: 3780841
DOI: 10.1007/BF00541461.
Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.
Verma S, Silke B, Reynolds G, Muller P, Frais M, Taylor S
Br J Clin Pharmacol. 1987; 24(1):21-32.
PMID: 3304383
PMC: 1386275.
DOI: 10.1111/j.1365-2125.1987.tb03131.x.
The treatment of heart failure. A methodological review of the literature.
Guyatt G
Drugs. 1986; 32(6):538-68.
PMID: 3024949
DOI: 10.2165/00003495-198632060-00004.
Lack of effect of bumetanide on body potassium content in hypertension.
MURCHISON L, BEWSHER P
Br J Clin Pharmacol. 1975; 2(1):87-91.
PMID: 1234492
PMC: 1402504.
DOI: 10.1111/j.1365-2125.1975.tb01691.x.
Bumetanide--acute and long term studies of a new high potency diuretic.
MURDOCH W, AULD W
Postgrad Med J. 1975; 51(591):10-4.
PMID: 1161670
PMC: 2495680.
DOI: 10.1136/pgmj.51.591.10.
Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema.
Brogden R, Speight T, Avery G
Drugs. 1975; 9(1):4-18.
PMID: 1126304
DOI: 10.2165/00003495-197509010-00002.
Editorial: Calcium, magnesium, and diuretics.
Br Med J. 1975; 1(5951):170-1.
PMID: 1111734
PMC: 1672161.
DOI: 10.1136/bmj.1.5951.170-a.
Diuretics: mechanism of action and clinical application.
Davies D, WILSON G
Drugs. 1975; 9(3):178-226.
PMID: 1092541
DOI: 10.2165/00003495-197509030-00003.
Fate of [14C]-bumetanide in man.
Pentikainen P, Penttila A, Neuvonen P, Gothoni G
Br J Clin Pharmacol. 1977; 4(1):39-44.
PMID: 843423
PMC: 1428996.
DOI: 10.1111/j.1365-2125.1977.tb00664.x.
Diuretic action of bumetanide in advanced chronic renal insufficiency.
Berg K, Tromsdal A, Wideroe T
Eur J Clin Pharmacol. 1976; 9(4):265-75.
PMID: 786692
DOI: 10.1007/BF00561659.
